Europe Hospital at Home Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Equipment and Devices and Software and Services), Service Type (Acute Care at Home, Chronic Disease Manag

According to our new research study on “Europe Hospital at Home Market Forecast to 2031 –Regional Analysis – by Product Type, Wound Type, and End User,” the market is anticipated to grow from US$ 8.44 billion in 2024 to US$ 13.57 billion by 2031; the market is expected to register a CAGR of 7.1% from 2025 to 2031. Europe hospital at home market growth is attributed to the rapidly aging population and rising prevalence of chronic diseases, constraints on hospital capacity, a shift toward ambulatory and community-based care, and advancements in digital health technologies accelerated by the COVID-19 pandemic.

Hospital at Home (HaH) provides care usually given in a hospital to a patient's home in a less risky way compared to the usual inpatient hospital stay. Different teams involved in the care may include giving treatments such as IV therapies, monitoring, nursing visits, and diagnostics at home, usually helped by remote technologies. Such an idea fits pneumonia, heart failure, COPD, infections, or recovery after surgery, thus the patient is exposed to fewer risks, such as hospital-acquired infections, while the results of the treatment are still the same. Widespread adoption of device-based remote monitoring in hospital-at-home models, hospital at home as a key driver for sustainable and green healthcare, integration of artificial intelligence for predictive and personalized hospital-at-home care are expected to emerge as major Europe hospital at home market trends in the coming years.

Europe hospital at home market is categorized into the Germany, UK, France, Italy, Spain, Netherlands, Switzerland, Belgium, and the Rest of Europe. According to the 'Health at a Glance: Europe 2024' report issued by the International Organisation for Economic Co-operation & Development (OECD), there is growing evidence as a result of various Tele-healthcare technologies, Tele-monitoring, Tele-consulting and Hospital-at-Home (HaH), of improved health outcomes, including lower rates of mortality and admission due to Congestive Heart Failure (CHF) and increased acceptance of residential care alternatives (i.e. HaH) as fewer hospitalized beds are being provided across Europe. The number of providers offering HaH services continue to increase throughout OECD nations due to policies directed toward sustainable healthcare for older adults with multimorbidity.

For instance, French Hospitalization à Domicile (HAD), which is one of the oldest forms of HaH, provides more than one million home care days every year. The National Health Service (NHS) in the UK operates Virtual Wards, a national-scale HaH service for managing the remote monitoring of frail individuals as well as those with chronic respiratory illnesses. In Spain, millions of patients receive regional HaH services through large, successful programmes in Catalonia, with similar success of care provided as through traditional inpatient hospital care settings. Portugal's large-scale HaH programme has proven successful in treating approximately 11,500 patients through virtual beds in 2024, supporting the concept of HaH's role in alleviating overcrowding in hospitals.

Numerous innovative care models in Europe are making use of new technologies and large-scale practice nursing aid to develop and provide improved transitional care and equity outcomes for patients living in rural communities as highlighted by WHO Europe analysis. Supporting European Union's focus on resilient healthcare systems, increased patient preference, lower emissions related to healthcare delivery, and efficiencies with regard to healthcare costs, these behaviors are also consistent with emerging priorities for reform in the EU.

The Hospital at Home (HaH) industry in Germany is expected to expand because of a growing elderly population and increasing healthcare costs. In 2024, it is projected that more than 22% of Germany’s population will be aged 65 and older, this is slightly higher than the predicted EU average (2024). Furthermore, because of these demographic changes, the need for long-term care in Germany is projected to increase by 37% by 2055. Germany is using digital innovation to provide acute care services through its HaH program and to reduce some of the reliance placed on its growing, extensive network of hospitals. The primary components of HaH are telemedicine and remote monitoring of people with chronic illnesses. One goal is to decrease the number of preventable hospital admissions within Germany for specific diseases such as heart failure or chronic obstructive pulmonary disease (COPD). For instance, the Telemedicine Centre at Robert Bosch Hospital provides data, including vital signs and telephone-based patient support, to chronic patients. On the other hand, the Institute for Applied Telemedicine (Institute für Angewandte Telemedizin: IFAT) has provided heart failure remote-monitoring services to approximately 11,000 patients through its telemonitoring program. An example of a recent initiative is the TELnet@NRW Project, which provides virtual consultation services within the NRW area, and has provided virtual service to over 20,000 patients since it began. The TELnet@NRW received approximately US$ 23.41 million in funding from the Federal Joint Committee for the purpose of improving the capacity to deliver intensive care services remotely. Step-by-step, the Digital Health Act of 2019 (Digitale Gesundheitsanwendungen - DGA) is paving the way for the use of telephonic consultations and prescriptions via health-related app usage, while recent legislation passed in early 2023 (Gesetz zur Beschleunigung der Digitalisierung, Accelerating the Digitalisation Act) mandates that by 2025, electronic records should be implemented for all patients, while electronic prescriptions, via e-mail or through a telemedicine service, will become mandatory by 2024.

The US Food and Drug Administration, National Institute of Health, are among the primary and secondary sources referred to while preparing the Middle East and North Africa advanced wound care market report.

Reasons to Buy

Saves and reduces time required for identifying the market growth, size, leading players, and segments in the Europe Hospital at Home market.
Highlights key business priorities to assist companies in realigning their business strategies
Emphasizes key findings and recommendations that uncover emerging industry trends in the Europe Hospital at Home market, enabling stakeholders across the value chain to craft effective long-term strategies
Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
Scrutinizes in-depth Europe Hospital at Home market trends, along with factors driving the market, as well as those hindering it
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution Show more